ImmuneXcite Obtains $3,579,950 New Round

  • Feed Type
  • Date
    1/7/2014
  • Company Name
    ImmuneXcite
  • Mailing Address
    3 Forbes Road Lexington, MA 02421
  • Company Description
    ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.
  • Website
    http://www.immunexcite.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,579,950
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy